|
Volumn 33, Issue 2, 2006, Pages 235-238
|
A long-term survivor with stage IV gastric cancer due to postoperative weekly paclitaxel and 5'-DFUR combination therapy
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
DOXIFLURIDINE;
FLOXURIDINE;
PACLITAXEL;
ARTICLE;
CANCER STAGING;
CASE REPORT;
DRUG ADMINISTRATION;
FEMALE;
GASTRECTOMY;
HUMAN;
LYMPH NODE;
LYMPH NODE METASTASIS;
LYMPHADENECTOMY;
METASTASIS;
MIDDLE AGED;
MULTIMODALITY CANCER THERAPY;
PATHOLOGY;
QUALITY OF LIFE;
SALVAGE THERAPY;
SIGNET RING CARCINOMA;
STOMACH TUMOR;
SURVIVOR;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, SIGNET RING CELL;
COMBINED MODALITY THERAPY;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
FLOXURIDINE;
GASTRECTOMY;
HUMANS;
LYMPH NODE EXCISION;
LYMPH NODES;
LYMPHATIC METASTASIS;
MIDDLE AGED;
NEOPLASM STAGING;
PACLITAXEL;
QUALITY OF LIFE;
SALVAGE THERAPY;
STOMACH NEOPLASMS;
SURVIVORS;
|
EID: 33644867432
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (2)
|
References (0)
|